Cargando…
Changing the Paradigm of Cancer Screening, Prevention, and Treatment
The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134297/ https://www.ncbi.nlm.nih.gov/pubmed/27928220 http://dx.doi.org/10.1177/1559325816680539 |
_version_ | 1782471439486550016 |
---|---|
author | Doss, Mohan |
author_facet | Doss, Mohan |
author_sort | Doss, Mohan |
collection | PubMed |
description | The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has reduced mortality from some cancers, but age-adjusted cancer mortality rates continue to be high. The lack of significant progress in reducing cancer mortality rates may be indicative of a fundamental flaw in the cancer model used. An alternative model of cancer is the immune suppression model of cancer based on the tremendous increase in cancers when the immune system is suppressed. According to this model, the key carcinogenic event is the suppression of the immune system which enables the already existing covert cancers to grow uncontrollably, causing cancer. Hence, cancer screening would consist of identifying those with weak immune system response. The primary mode of cancer prevention and treatment would be boosting of the immune system, for example, through exercise, infection, and low-dose radiation, as they are all known to enhance immune system response and reduce cancers. There is sufficient evidence to justify clinical trials of this approach for cancer screening, prevention, and treatment. |
format | Online Article Text |
id | pubmed-5134297 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-51342972016-12-07 Changing the Paradigm of Cancer Screening, Prevention, and Treatment Doss, Mohan Dose Response Invited Review The war on cancer has been fought during the past several decades primarily based on the somatic mutation model of cancer. This has resulted in the emphasis on cancer screening and elimination of any detected cancerous/precancerous cells as the primary method of cancer prevention. This approach has reduced mortality from some cancers, but age-adjusted cancer mortality rates continue to be high. The lack of significant progress in reducing cancer mortality rates may be indicative of a fundamental flaw in the cancer model used. An alternative model of cancer is the immune suppression model of cancer based on the tremendous increase in cancers when the immune system is suppressed. According to this model, the key carcinogenic event is the suppression of the immune system which enables the already existing covert cancers to grow uncontrollably, causing cancer. Hence, cancer screening would consist of identifying those with weak immune system response. The primary mode of cancer prevention and treatment would be boosting of the immune system, for example, through exercise, infection, and low-dose radiation, as they are all known to enhance immune system response and reduce cancers. There is sufficient evidence to justify clinical trials of this approach for cancer screening, prevention, and treatment. SAGE Publications 2016-11-30 /pmc/articles/PMC5134297/ /pubmed/27928220 http://dx.doi.org/10.1177/1559325816680539 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Invited Review Doss, Mohan Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title | Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title_full | Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title_fullStr | Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title_full_unstemmed | Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title_short | Changing the Paradigm of Cancer Screening, Prevention, and Treatment |
title_sort | changing the paradigm of cancer screening, prevention, and treatment |
topic | Invited Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5134297/ https://www.ncbi.nlm.nih.gov/pubmed/27928220 http://dx.doi.org/10.1177/1559325816680539 |
work_keys_str_mv | AT dossmohan changingtheparadigmofcancerscreeningpreventionandtreatment |